Herborium Group Begins Commercialization of Its Sexual Health Products to Enter $3.5 billion Market
FORT LEE, N.J., June 20, 2012 /PRNewswire/ — Herborium Group, Inc., (HBRM) www.herborium.com, a Botanical Therapeutics® Company announces today that it has begun manufacturing its new sexual health product line for women and men. Herborium proprietary products will launch in the Fall of 2012 in coordination with a promotion of a unique Kamasutra vodka product with natural herbs provided by Herborium and developed based on a know-how associated with the company’s sexual health formulations. Kamasutra (USA) LLC is a US partner of the German Bismarck Premium Brands GmbH, www.bismarck.de and http://www.bismarck.de/kamasutra/englisch/kamasutra_ginseng_vodka.html.
In addition to revenue sharing (vodka market in the US is estimated to exceed $4.8 billion) and licensing fees to be received by Herborium Group in association with Kamasutra vodka beverage, Herborium plans on leveraging Kamasutra’s promotional strategy linked to Herborium sexual health product line that provides unprecedented exposure and promotional opportunities for Herborium women and men products.
Herborium goal is to make a direct impact on over $1.5 billion natural sexual health products market and also to position its products against the market for pharmaceutical grade sexual health products that is over $3.2 billion worldwide, with Viagra (Pfizer), Cialis (Eli Lilly) and Levitra (Bayer) leading market share. Rising costs of pharmaceutical grade drugs combined with safety concerns drive consumers to look for natural alternatives in a sexual health products category and Herborium’s sexual health formulas are all herbal, proven effective and safe.
There is no Viagra comparative product on the market for women. Herborium sexual formulation for women will be the only product of its kind on the market. Female sexual enhancement industry is expected to grow into a multibillion dollar business especially since women themselves are becoming increasingly aware of their sexuality and their sexual health. First-quarter sales of personal lubricants in the USA soared 32% to $41.2 million, according to Information Resources Inc. Herborium product for women is the only all herbal, proven effective and safe sexual health and enhancement product for women that improves both a satisfaction and libido (sexual drive).
Dr. Agnes Olszewski, Chairman and CEO of Herborium, stated: “We believe that this is the right time to commercialize our all herbal, proprietary products women and men. There is nothing on the market as our systemic all herbal product for women. Unlike many supplements claiming to improve sexual performance both our products include only herbal ingredients recognized for their safety. Both products developed by Herborium are based on a combination of Principles of Traditional Chinese Medicine and modern sexual health science, have confirmed up to 98% efficacy and improve performance and experience for those men and women with sexual performance problems and those seeking recreational sexual enhancement. Products have no known adverse effects.
“By combining unique characteristics of Herborium sexual health Botanical Therapeutics® with a strong marketing exposure and growing demand, and awareness regarding sexual health, we expect our products to gain market acceptance and start generating revenues as early as 2012, with an exponential growth in the next 12 months. Distribution arrangements are presently being made,” concluded Dr. Olszewski.
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company uses clinical validation to establish and maintain a differential advantage. The company sells its products in the US and Europe. For more information, please visit www.herborium.com and www.acnease.com.
One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered “forward-looking statements,” generally preceded by words such as “plans,” “expects,” “believes,” “anticipates,” or “intends.” We cannot promise future returns. Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.
For more information please inquire: Investorsrelations@herborium.com
SOURCE Herborium Group, Inc.